skip to main content
Washington State Institute for Public Policy

Benefit–Cost Evaluation of Obesity Treatments

WSIPP is partnering with the Washington State Office of the Insurance Commissioner to evaluate the monetary benefits and costs of selected obesity treatments. Using a meta-analytic approach, WSIPP will assess the effectiveness of interventions such as bariatric surgery, FDA-approved weight-loss medications (GLP-1s), and behavioral or lifestyle programs. The analysis will translate impacts on outcomes like obesity, weight loss, and diabetes into monetary terms using WSIPP’s benefit–cost model, providing policymakers with clear, evidence-based insights.

The project will be completed in September 2026.
Morgan Spangler, (360) 664-9807